Skip to main content

Stereotactic Surgery Devices Market Trend, Size and Top Key Player Comprehensive Analysis 2020

Stereotactic Surgery Devices Market By Product Type (gamma Knife, Linear Accelerators, Proton Beam Therapy, Cyberknife), by Application (Brain Tumour, Arteriovenous Malformations, Parkinson’s disease, Epilepsy, Other)—Forecast till 2023.
Global stereotactic surgery devices market is growing rapidly mainly due to the growing prevalence of neurological diseases and disorders. Moreover, factors such as the increasing preference for minimally invasive surgeries and the increasing prevalence of brain-related diseases such as Parkinson’s disease are escalating the market on the global platform.
The Stereotactic Surgery Devices Market is witnessing currently asserts that will garner exponential accruals by 2023, registering 5.2% CAGR throughout the forecast period (2018-2023).
Due to the increasing competition in the market, multination companies are using the strategy of acquisition, which has increased the profit of the company as well as significantly reduced the competition. Key players leading the global stereotactic surgery devices market include –
Huiheng Medical Inc.
Koninklijke Philips N.V.
Mitsubishi Heavy Industries Ltd.
Varian Medical Systems
GE Healthcare
Hitachi Medical Systems
Ferring B. V.
Accuray Inc.
Elekta AB
Shinva Medical Instrument Co. Ltd
and among others.
Additional factors having a synergistic effect on the growth of the stereotactic surgery devices market include the increasing number of technological advancements, increasing number of ambulatory services, and government initiatives.
Segments Overview
The global stereotactic surgery devices market has been segmented into product type and application.
The global market, on the basis of product type, has been segmented into gamma knife, Linear accelerators (LINAC), proton beam therapy, and cyberknife. By product type, linear accelerators (LINAC) segment is expected to hold largest market share owing to the growing adoption rate and installations. Additionally, cyberknife is expected to be the fastest growing segment over the assessment period owing to its growing popularity in the developing economies.
On the basis of application, the market has been segmented into brain tumor, arteriovenous malformations, Parkinson’s disease, epilepsy, and others.
LIST OF TABLES
Table 1 Global Stereotactic Surgery Devices Market Synopsis, 2018–2023
Table 2 Global Stereotactic Surgery Devices Market Estimates and Forecast, 2018–2023 (USD Million)
Table 3 Global Stereotactic Surgery Devices Market, by Region, 2018–2023 (USD Million)
Table 4 Global Stereotactic Surgery Devices Market, by Product Type, 2018–2023 (USD Million)
Table 5 Global Stereotactic Surgery Devices Market, by Application, 2018–2023 (USD Million)
Table 6 North America: Stereotactic Surgery Devices Market, by Product Type, 2018–2023 (USD Million)
Table 7 North America: Stereotactic Surgery Devices Market, by Application, 2018–2023 (USD Million)
…To be Continued.
Geographically, the Americas is expected to dominate the global market owing to the rising prevalence of neurological diseases, presence of developed healthcare infrastructure, and high disposable income. Europe is anticipated to hold the second largest position in the global stereotactic surgery devices market. The market growth in this region is mainly due to the increasing occurrences of brain diseases and presence of developed healthcare sector. The Asia-Pacific region is expected to be fastest growing region owing to the growing prevalence of brain-related diseases and continuously growing healthcare sector. The Middle East & Africa has the least share of the market owing to the limited presence of developed healthcare infrastructure in the African region.
About Market Research Future: Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312

Comments

Popular posts from this blog

Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Growth Drivers, Restraints and Opportunities, Forecast To 2025

Global Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Size Research Report: Information by Treatment (Drug Class (Mitogen-Activated Protein Kinases (MAPK) Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors, Others), Oxygen Therapy, Lung Transplant, Others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025 Global  Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Size  Insights 2020 provides a unique tool for evaluating the Market, highlighting opportunities, and supporting strategic and tactical decision-making. This report recognizes that in this rapidly-evolving and competitive environment, up-to-date Marketing information is essential to monitor performance and make critical decisions for growth and profitability. Some of the key players operating for the global market analysis are  Boehringer Ingelheim GMBH, Biogen, Novartis AG, Medicinova, Inc., Bristol-Myers Squibb Company, Galapagos NV, F. Hoffmann-La R...

Peptic Ulcer Drugs Market Rapid Development By Manufactures Business Growth Future

  Peptic Ulcer Drugs Market Scenario: Peptic ulcer drugs are used to treat erosion of the gastrointestinal lining due to a variety of factors. Peptic ulcer is the result of an imbalance between aggressive and defensive fluids in the stomach. Peptic ulcer includes gastric, esophageal and duodenal ulcer. The global peptic ulcer drugs market was valued at approximately $29 billion in 2015, and is expected to reach $36.27 billion by 2022. Thus, the market is expected to show an average growth at a CAGR of 3.8 % from 2016 to 2022. The major driving factors for petic ulcers drug market are stress, drug induced ulcers, growing rate of infection by H.Pyrroli, changes in food, rise in cancer, tobacco and alcohol use. Constraining factors of this market are patent expiry, comparatively good treatment regimen of proton pump inhibitors, resistance of H.Pyrolli, extreme market fragmentation into many companies and great penetration of generics. Avail a Free Sample@  https://www.market...

Middle East And Africa Pediatric Healthcare Market Development Research with Forthcoming Opportunities and Challenges

  Middle East And Africa Pediatric Healthcare Market Share, Application And Growth Analysis, By Type Of Diseases (Short Term Diseases, Chronic Diseases And Others), By Therapeutics (Cardiology, Allergy And Immunology, Gastroenterology, Infectious Disease And Others), By Treatment (Medication, Surgery, And Others) - Forecast To 2023 Paediatric Healthcare-Overview Paediatrics is a branch of medicine which deals with diagnosis and treatment of diseases related to paediatric group. It can be classified into the four categories namely neonates (from birth till the first 28 days of life), infants (29 days to 2 years), children (2 years to 12 years) and adolescents (12 years to 18 years). Paediatrician is a medical professional who specializes in providing treating the paediatric group. Paediatric medical devices are devices used for the treatment and care of infants and children below 18 years having some healthcare issues. Avail a Free Sample@  https://www.marketresearchfuture.com/...